Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

ICAgen receive SBIR grant for ion channel drug target research

Nov. 11, 1997

Proof of principle demonstrated for Titan's drug delivery system

Nov. 11, 1997

Myriad creates CNS database for potential drug discovery

Nov. 7, 1997

U.S. patent issued for Cambridge NeuroScience's drug delivery system

Nov. 6, 1997

Genetronics cleared to proceed with electroporation trial in France

Nov. 6, 1997

CellPro: Q2 1997 highlights

Nov. 6, 1997

Karo Bio/Merck & Co. form strategic alliance related to ER receptors

Nov. 5, 1997

FibroGen granted license to Zeneca antifibrotic compounds

Nov. 3, 1997

Genzyme General and Acadia enter drug discovery collaboration

Nov. 3, 1997

Laminin-like peptides available for licensing from NIH

Nov. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...